.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Accenture
AstraZeneca
QuintilesIMS
Medtronic
Argus Health
Moodys
UBS
US Army
Chinese Patent Office

Generated: December 18, 2017

DrugPatentWatch Database Preview

AVEED Drug Profile

« Back to Dashboard

Which patents cover Aveed, and when can generic versions of Aveed launch?

Aveed is a drug marketed by Endo Pharms Inc and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has fifty patent family members in thirty-seven countries.

The generic ingredient in AVEED is testosterone undecanoate. There are sixty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the testosterone undecanoate profile page.

Summary for AVEED

Drug patent expirations by year for AVEED

Pharmacology for AVEED

Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharms IncAVEEDtestosterone undecanoateINJECTABLE;INTRAMUSCULAR022219-001Mar 5, 2014RXYesYes► Subscribe► SubscribeY► Subscribe
Endo Pharms IncAVEEDtestosterone undecanoateINJECTABLE;INTRAMUSCULAR022219-001Mar 5, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Endo Pharms IncAVEEDtestosterone undecanoateINJECTABLE;INTRAMUSCULAR022219-001Mar 5, 2014RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for AVEED

Drugname Dosage Strength RLD Submissiondate
testosterone undecanoateInjection250 mg/mLAveed6/11/2014

International Patent Family for Tradename: AVEED

Country Document Number Estimated Expiration
China1761469► Subscribe
Germany602004001893► Subscribe
Japan2006520377► Subscribe
Iceland2565► Subscribe
South Africa200700046► Subscribe
Australia2004218893► Subscribe
Norway20054711► Subscribe
Argentina043603► Subscribe
Ukraine82510► Subscribe
Eurasian Patent Organization200501819► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Merck
Daiichi Sankyo
UBS
Johnson and Johnson
Argus Health
McKesson
US Army
Novartis
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot